Treatment Resources

Federal Resources 

  • Sign up to receive the FDA’s COVID-19 email updates here.  

  • The Coronavirus Treatment Acceleration Program (CTAP) is a special FDA emergency program created to develop possible COVID-19 therapies.  The program uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful. The program supports clinical trials that are testing new treatments for COVID to gain valuable knowledge about their safety and effectiveness.  

See the CTAP Frequently Asked Questions for more information. 

State Resources 

  • The Pennsylvania Department of Health (DOH) has a provider portal with information for healthcare providers regarding COVID-19 therapeutics. This information is not intended for the general public. 

  • You can access the DOH information for the general public regarding COVID-19 therapeutics here.